Literature DB >> 31142819

Combined cellomics and proteomics analysis reveals shared neuronal morphology and molecular pathway phenotypes for multiple schizophrenia risk genes.

Patrick F Sullivan1,2,3, August B Smit4, Ronald E van Kesteren5, Martina Rosato4, Sven Stringer6, Titia Gebuis4, Iryna Paliukhovich4, Ka Wan Li4, Danielle Posthuma6.   

Abstract

An enigma in studies of neuropsychiatric disorders is how to translate polygenic risk into disease biology. For schizophrenia, where > 145 significant GWAS loci have been identified and only a few genes directly implicated, addressing this issue is a particular challenge. We used a combined cellomics and proteomics approach to show that polygenic risk can be disentangled by searching for shared neuronal morphology and cellular pathway phenotypes of candidate schizophrenia risk genes. We first performed an automated high-content cellular screen to characterize neuronal morphology phenotypes of 41 candidate schizophrenia risk genes. The transcription factors Tcf4 and Tbr1 and the RNA topoisomerase Top3b shared a neuronal phenotype marked by an early and progressive reduction in synapse numbers upon knockdown in mouse primary neuronal cultures. Proteomics analysis subsequently showed that these three genes converge onto the syntaxin-mediated neurotransmitter release pathway, which was previously implicated in schizophrenia, but for which genetic evidence was weak. We show that dysregulation of multiple proteins in this pathway may be due to the combined effects of schizophrenia risk genes Tcf4, Tbr1, and Top3b. Together, our data provide new biological functions for schizophrenia risk genes and support the idea that polygenic risk is the result of multiple small impacts on common neuronal signaling pathways.

Entities:  

Mesh:

Year:  2019        PMID: 31142819      PMCID: PMC7910218          DOI: 10.1038/s41380-019-0436-y

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  61 in total

1.  Schizophrenia in a patient with subtelomeric duplication of chromosome 22q.

Authors:  P Failla; C Romano; A Alberti; A Vasta; S Buono; L Castiglia; D Luciano; D Di Benedetto; M Fichera; O Galesi
Journal:  Clin Genet       Date:  2007-06       Impact factor: 4.438

Review 2.  The genomics of schizophrenia: update and implications.

Authors:  Paola Giusti-Rodríguez; Patrick F Sullivan
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

3.  Analysis of the association of VIPR2 polymorphisms with susceptibility to schizophrenia.

Authors:  Chunhui Jin; Zhenhe Zhou; Weidong Li; Fuquan Zhang; Jianmin Yuan; Xiaowei Liu; Zaohuo Cheng
Journal:  Psychiatry Res       Date:  2016-04-27       Impact factor: 3.222

4.  Truncating mutations in RBM12 are associated with psychosis.

Authors:  Stacy Steinberg; Steinunn Gudmundsdottir; Gardar Sveinbjornsson; Jaana Suvisaari; Tiina Paunio; Minna Torniainen-Holm; Michael L Frigge; Gudrun A Jonsdottir; Johanna Huttenlocher; Sunna Arnarsdottir; Oddur Ingimarsson; Magnus Haraldsson; Thorarinn Tyrfingsson; Thorgeir E Thorgeirsson; Augustine Kong; Gudmundur L Norddahl; Daniel F Gudbjartsson; Engilbert Sigurdsson; Hreinn Stefansson; Kari Stefansson
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

5.  Genetic analysis of GABRB3 at 15q12 as a candidate gene of schizophrenia.

Authors:  Chia-Chun Huang; Min-Chih Cheng; Ho-Min Tsai; Chih-Hao Lai; Chia-Hsiang Chen
Journal:  Psychiatr Genet       Date:  2014-08       Impact factor: 2.458

Review 6.  The role of genetics in the etiology of schizophrenia.

Authors:  Pablo V Gejman; Alan R Sanders; Jubao Duan
Journal:  Psychiatr Clin North Am       Date:  2010-03

7.  Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders.

Authors:  Georg Stoll; Olli P H Pietiläinen; Bastian Linder; Jaana Suvisaari; Cornelia Brosi; William Hennah; Virpi Leppä; Minna Torniainen; Samuli Ripatti; Sirpa Ala-Mello; Oliver Plöttner; Karola Rehnström; Annamari Tuulio-Henriksson; Teppo Varilo; Jonna Tallila; Kati Kristiansson; Matti Isohanni; Jaakko Kaprio; Johan G Eriksson; Olli T Raitakari; Terho Lehtimäki; Marjo-Riitta Jarvelin; Veikko Salomaa; Matthew Hurles; Hreinn Stefansson; Leena Peltonen; Patrick F Sullivan; Tiina Paunio; Jouko Lönnqvist; Mark J Daly; Utz Fischer; Nelson B Freimer; Aarno Palotie
Journal:  Nat Neurosci       Date:  2013-08-04       Impact factor: 24.884

8.  Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.

Authors:  Christian R Marshall; Daniel P Howrigan; Daniele Merico; Bhooma Thiruvahindrapuram; Wenting Wu; Douglas S Greer; Danny Antaki; Aniket Shetty; Peter A Holmans; Dalila Pinto; Madhusudan Gujral; William M Brandler; Dheeraj Malhotra; Zhouzhi Wang; Karin V Fuentes Fajarado; Michelle S Maile; Stephan Ripke; Ingrid Agartz; Margot Albus; Madeline Alexander; Farooq Amin; Joshua Atkins; Silviu A Bacanu; Richard A Belliveau; Sarah E Bergen; Marcelo Bertalan; Elizabeth Bevilacqua; Tim B Bigdeli; Donald W Black; Richard Bruggeman; Nancy G Buccola; Randy L Buckner; Brendan Bulik-Sullivan; William Byerley; Wiepke Cahn; Guiqing Cai; Murray J Cairns; Dominique Campion; Rita M Cantor; Vaughan J Carr; Noa Carrera; Stanley V Catts; Kimberley D Chambert; Wei Cheng; C Robert Cloninger; David Cohen; Paul Cormican; Nick Craddock; Benedicto Crespo-Facorro; James J Crowley; David Curtis; Michael Davidson; Kenneth L Davis; Franziska Degenhardt; Jurgen Del Favero; Lynn E DeLisi; Dimitris Dikeos; Timothy Dinan; Srdjan Djurovic; Gary Donohoe; Elodie Drapeau; Jubao Duan; Frank Dudbridge; Peter Eichhammer; Johan Eriksson; Valentina Escott-Price; Laurent Essioux; Ayman H Fanous; Kai-How Farh; Martilias S Farrell; Josef Frank; Lude Franke; Robert Freedman; Nelson B Freimer; Joseph I Friedman; Andreas J Forstner; Menachem Fromer; Giulio Genovese; Lyudmila Georgieva; Elliot S Gershon; Ina Giegling; Paola Giusti-Rodríguez; Stephanie Godard; Jacqueline I Goldstein; Jacob Gratten; Lieuwe de Haan; Marian L Hamshere; Mark Hansen; Thomas Hansen; Vahram Haroutunian; Annette M Hartmann; Frans A Henskens; Stefan Herms; Joel N Hirschhorn; Per Hoffmann; Andrea Hofman; Hailiang Huang; Masashi Ikeda; Inge Joa; Anna K Kähler; René S Kahn; Luba Kalaydjieva; Juha Karjalainen; David Kavanagh; Matthew C Keller; Brian J Kelly; James L Kennedy; Yunjung Kim; James A Knowles; Bettina Konte; Claudine Laurent; Phil Lee; S Hong Lee; Sophie E Legge; Bernard Lerer; Deborah L Levy; Kung-Yee Liang; Jeffrey Lieberman; Jouko Lönnqvist; Carmel M Loughland; Patrik K E Magnusson; Brion S Maher; Wolfgang Maier; Jacques Mallet; Manuel Mattheisen; Morten Mattingsdal; Robert W McCarley; Colm McDonald; Andrew M McIntosh; Sandra Meier; Carin J Meijer; Ingrid Melle; Raquelle I Mesholam-Gately; Andres Metspalu; Patricia T Michie; Lili Milani; Vihra Milanova; Younes Mokrab; Derek W Morris; Bertram Müller-Myhsok; Kieran C Murphy; Robin M Murray; Inez Myin-Germeys; Igor Nenadic; Deborah A Nertney; Gerald Nestadt; Kristin K Nicodemus; Laura Nisenbaum; Annelie Nordin; Eadbhard O'Callaghan; Colm O'Dushlaine; Sang-Yun Oh; Ann Olincy; Line Olsen; F Anthony O'Neill; Jim Van Os; Christos Pantelis; George N Papadimitriou; Elena Parkhomenko; Michele T Pato; Tiina Paunio; Diana O Perkins; Tune H Pers; Olli Pietiläinen; Jonathan Pimm; Andrew J Pocklington; John Powell; Alkes Price; Ann E Pulver; Shaun M Purcell; Digby Quested; Henrik B Rasmussen; Abraham Reichenberg; Mark A Reimers; Alexander L Richards; Joshua L Roffman; Panos Roussos; Douglas M Ruderfer; Veikko Salomaa; Alan R Sanders; Adam Savitz; Ulrich Schall; Thomas G Schulze; Sibylle G Schwab; Edward M Scolnick; Rodney J Scott; Larry J Seidman; Jianxin Shi; Jeremy M Silverman; Jordan W Smoller; Erik Söderman; Chris C A Spencer; Eli A Stahl; Eric Strengman; Jana Strohmaier; T Scott Stroup; Jaana Suvisaari; Dragan M Svrakic; Jin P Szatkiewicz; Srinivas Thirumalai; Paul A Tooney; Juha Veijola; Peter M Visscher; John Waddington; Dermot Walsh; Bradley T Webb; Mark Weiser; Dieter B Wildenauer; Nigel M Williams; Stephanie Williams; Stephanie H Witt; Aaron R Wolen; Brandon K Wormley; Naomi R Wray; Jing Qin Wu; Clement C Zai; Rolf Adolfsson; Ole A Andreassen; Douglas H R Blackwood; Elvira Bramon; Joseph D Buxbaum; Sven Cichon; David A Collier; Aiden Corvin; Mark J Daly; Ariel Darvasi; Enrico Domenici; Tõnu Esko; Pablo V Gejman; Michael Gill; Hugh Gurling; Christina M Hultman; Nakao Iwata; Assen V Jablensky; Erik G Jönsson; Kenneth S Kendler; George Kirov; Jo Knight; Douglas F Levinson; Qingqin S Li; Steven A McCarroll; Andrew McQuillin; Jennifer L Moran; Bryan J Mowry; Markus M Nöthen; Roel A Ophoff; Michael J Owen; Aarno Palotie; Carlos N Pato; Tracey L Petryshen; Danielle Posthuma; Marcella Rietschel; Brien P Riley; Dan Rujescu; Pamela Sklar; David St Clair; James T R Walters; Thomas Werge; Patrick F Sullivan; Michael C O'Donovan; Stephen W Scherer; Benjamin M Neale; Jonathan Sebat
Journal:  Nat Genet       Date:  2016-11-21       Impact factor: 38.330

9.  Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.

Authors:  Tarjinder Singh; Mitja I Kurki; David Curtis; Shaun M Purcell; Lucy Crooks; Jeremy McRae; Jaana Suvisaari; Himanshu Chheda; Douglas Blackwood; Gerome Breen; Olli Pietiläinen; Sebastian S Gerety; Muhammad Ayub; Moira Blyth; Trevor Cole; David Collier; Eve L Coomber; Nick Craddock; Mark J Daly; John Danesh; Marta DiForti; Alison Foster; Nelson B Freimer; Daniel Geschwind; Mandy Johnstone; Shelagh Joss; Georg Kirov; Jarmo Körkkö; Outi Kuismin; Peter Holmans; Christina M Hultman; Conrad Iyegbe; Jouko Lönnqvist; Minna Männikkö; Steve A McCarroll; Peter McGuffin; Andrew M McIntosh; Andrew McQuillin; Jukka S Moilanen; Carmel Moore; Robin M Murray; Ruth Newbury-Ecob; Willem Ouwehand; Tiina Paunio; Elena Prigmore; Elliott Rees; David Roberts; Jennifer Sambrook; Pamela Sklar; David St Clair; Juha Veijola; James T R Walters; Hywel Williams; Patrick F Sullivan; Matthew E Hurles; Michael C O'Donovan; Aarno Palotie; Michael J Owen; Jeffrey C Barrett
Journal:  Nat Neurosci       Date:  2016-03-14       Impact factor: 24.884

10.  Identification of the BRD1 interaction network and its impact on mental disorder risk.

Authors:  Tue Fryland; Jane H Christensen; Jonatan Pallesen; Manuel Mattheisen; Johan Palmfeldt; Mads Bak; Jakob Grove; Ditte Demontis; Jenny Blechingberg; Hong Sain Ooi; Mette Nyegaard; Mads E Hauberg; Niels Tommerup; Niels Gregersen; Ole Mors; Thomas J Corydon; Anders L Nielsen; Anders D Børglum
Journal:  Genome Med       Date:  2016-05-03       Impact factor: 11.117

View more
  7 in total

Review 1.  The many lives of type IA topoisomerases.

Authors:  Anna H Bizard; Ian D Hickson
Journal:  J Biol Chem       Date:  2020-04-10       Impact factor: 5.157

Review 2.  Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes.

Authors:  Jacopo Sapienza; Marta Bosia; Marco Spangaro; Francesca Martini; Giulia Agostoni; Federica Cuoco; Federica Cocchi; Roberto Cavallaro
Journal:  Mol Psychiatry       Date:  2022-08-05       Impact factor: 13.437

Review 3.  Advances in Proteomics Allow Insights Into Neuronal Proteomes.

Authors:  Erin Fingleton; Yan Li; Katherine W Roche
Journal:  Front Mol Neurosci       Date:  2021-04-15       Impact factor: 5.639

Review 4.  Human topoisomerases and their roles in genome stability and organization.

Authors:  Yves Pommier; André Nussenzweig; Shunichi Takeda; Caroline Austin
Journal:  Nat Rev Mol Cell Biol       Date:  2022-02-28       Impact factor: 113.915

5.  Analysis of Molecular Networks in the Cerebellum in Chronic Schizophrenia: Modulation by Early Postnatal Life Stressors in Murine Models.

Authors:  América Vera-Montecinos; Ricard Rodríguez-Mias; Karina S MacDowell; Borja García-Bueno; Álvaro G Bris; Javier R Caso; Judit Villén; Belén Ramos
Journal:  Int J Mol Sci       Date:  2021-09-17       Impact factor: 5.923

6.  Neuron-specific translational control shift ensures proteostatic resilience during ER stress.

Authors:  Kimberly Wolzak; Anna Nölle; Margherita Farina; Truus Em Abbink; Marjo S van der Knaap; Matthijs Verhage; Wiep Scheper
Journal:  EMBO J       Date:  2022-07-06       Impact factor: 14.012

7.  Age-Dependent Hippocampal Proteomics in the APP/PS1 Alzheimer Mouse Model: A Comparative Analysis with Classical SWATH/DIA and directDIA Approaches.

Authors:  Sophie J F van der Spek; Miguel A Gonzalez-Lozano; Frank Koopmans; Suzanne S M Miedema; Iryna Paliukhovich; August B Smit; Ka Wan Li
Journal:  Cells       Date:  2021-06-24       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.